Kezar Life Sciences, Inc. Recorded Big Gain
Mon, Feb 10, 2020 at 05:41 PM
Kezar Life Sciences, Inc. (KZR:NASDAQ) rocketted at $5.02, a gain of 34.6%. On Fri 07 Feb 20, KZR:NASDAQ touched a New 2-Week Intraday High of $4.95. The stock appeared on our News Catalysts scanner on Tue 04 Feb 20 at 09:07 PM in the 'PUBLIC OFFERING' category. From Fri 17 Jan 20, the stock recorded 28.57% Up Days and 26.67% Green Days
About Kezar Life Sciences, Inc. (KZR:NASDAQ)
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Top 10 Gainers:
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 1335.24%
- Precigen, Inc. (XON:NYSE), 293.2%
- Precigen, Inc. (XON:NASDAQ), 293.2%
- Taubman Centers, Inc. (TCO:NYSE), 53.22%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 52.38%
- Youdao, Inc. (DAO:NYSE), 39.48%
- Kezar Life Sciences, Inc. (KZR:NASDAQ), 34.58%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 32%
- Advaxis, Inc. (ADXS:NASDAQ), 28.71%
- Edgewell Personal Care Company (EPC:NYSE), 27.53%